EMCDDA news

ECDC and EMCDDA make the case for active case finding of communicable diseases in prison

What are the most (cost-) effective ways to prevent and control communicable diseases in prison settings? In their joint public health Guidance, ECDC and the EMCDDA present evidence on active case finding as a key measure to diagnose communicable diseases early. The publication is launched in the first Spring European Hepatitis-HIV Testing Week (18–25 May 2018). 23.05.2018 
Čtěte více

EMCDDA Director addresses Lithuanian drug policy conference

EMCDDA Director Alexis Goosdeel will address a conference hosted by the Lithuanian Drug, Tobacco and Alcohol Control Department (NTAKD) in Vilnius today, as the organisation prepares to present a new strategy (2018–2028) to the Lithuanian parliament and government. Dedicated to Lithuania’s drug policy review, with its human rights and health approach, the conference will underline the importance of a balanced and long-term drug policy, geared towards the creation of a healthy and safe society. 15.05.2018 
Čtěte více

Two new synthetic cannabinoids to be placed under control across the EU

Council implementing decision to control ADB-CHMINACA and CUMYL-4CN-BINACA 14.05.2018  Today the European Union has decided to subject two new synthetic cannabinoids to control measures across the 28 Member States. The substances in question are ADB-CHMINACA and CUMYL-4CN-BINACA, which have been raising health concerns in Europe.
Čtěte více

TOPlist